Class 4 medicine recall 5 January 2017

Class 4 Caution in Use : Mirena 20 micrograms / 24 hours intrauterine delivery system

Yes – this has been recalled
The problem
Bayer plc has informed us that they have received two complaints globally concerning Mirena inserters with an insertion tube which is mounted inversely to the handle
What to do
Check the batch number on your pack against the list below. Do not stop taking a prescribed medicine without talking to your pharmacist, GP or prescriber first – they can check your supply and swap it if needed.
Source: Medicines and Healthcare products Regulatory Agency (MHRA) Official notice ↗

Product Information

EL number

EL 17(A) 02

MDR number

MDR 051-12/16

Product description

Mirena 20 micrograms / 24 hours intrauterine delivery system – PL 0001/0547

  • Batch number: TU01BPE
  • Expiry Date: June 2019
  • Pack Size: 1×1
  • First Distributed: 29 August 2016

Brief description of the problem

Bayer plc has informed us that they have received two complaints globally concerning Mirena inserters with an insertion tube which is mounted inversely to the handle. This has resulted in inversion of the insertion depth scale, which may lead to incorrect insertion depth and the possibility of a reduced efficacy or adverse events. A very small number of Mirena inserters may potentially be affected by this issue.

An investigation has shown that both complaints involve one batch of inserters and Mirena batch TU01BPE has been manufactured using inserters from the same batch.

Any incorrectly mounted insertion tubes identified should be reported to Bayer plc by telephone,
01635 563116 or by email to medical.information@bayer.co.uk

Download document

Mirena 20 micrograms / 24 hours intrauterine delivery system

More detailed advice for Healthcare Professionals can be found in the attached letter, which has also been distributed by Bayer.

Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. NHS Regional Teams are asked to forward this to relevant clinics, general practitioners and community pharmacists.

Updated 5 January 2017. This page summarises an official notice. Details can change – always follow the official notice.

Website built by: www.NocturnalMedia.co.uk